Tokyo, Japan, Dec 21, 2006 - (JCN Newswire) - Astellas Pharma Inc. (TSE: 4503) today announced that Temmler Group, German pharmaceutical company and Astellas have reached an agreement and concluded a contract providing for the transfer by Astellas of bulk assets comprising the Munich Plant and Klinge Ireland Plant of Astellas Deutschland GmbH, and all stocks of Produzioni Farmaceutiche Carugate S.r.l, to Temmler Group.
